Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TuBiomics’ flagship product TBH-003, a natural chemistry herbicide derived from microbial mixtures, has advanced to commercial readiness and is being positioned for entry in organic agriculture, vegetation management, and home & garden markets. Early data indicate efficacy in suppressing eight significant soil-borne diseases on key crops including garlic, leafy greens, and strawberries[1][2][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TuBiomics.